Get started
Galapagos NV Sponsored ADRGalapagos NV Sponsored ADRGalapagos NV Sponsored ADR

Galapagos NV Sponsored ADR

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.19 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−7.44 USD
Net income (FY)
‪80.13 M‬ USD
Revenue (FY)
‪298.17 M‬ USD
Shares float
‪49.19 M‬
Beta (1Y)
0.74

About Galapagos NV


Sector
Health Technology
Industry
Biotechnology
CEO
Henry O. Gosebruch
Website
galapagos.com
Headquarters
Mechelen
Founded
1999
IPO date
May 6, 2005
Identifiers
3
ISIN US36315X1019
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Check out other big names from the same industry as GLPG.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IBB
iShares Biotechnology ETF
Weight
0.11%
Market value
‪9.16 M‬
USD
SBIO
ALPS Medical Breakthroughs ETF
Weight
1.42%
Market value
‪1.91 M‬
USD
APIE
ActivePassive International Equity ETF
Weight
0.05%
Market value
‪468.29 K‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.03%
Market value
‪324.59 K‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.03%
Market value
‪324.59 K‬
USD
AVDS
Avantis International Small Cap Equity ETF
Weight
0.08%
Market value
‪181.32 K‬
USD
SBIO
Invesco NASDAQ Biotech UCITS ETF
Weight
0.04%
Market value
‪157.59 K‬
USD
CURE
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD
Weight
0.32%
Market value
‪50.94 K‬
USD
203780
MIRAE ASSET TIGER NASDAQ BIO ETF
Weight
0.04%
Market value
‪27.20 K‬
USD
IBBQ
Invesco Nasdaq Biotechnology ETF
Weight
0.04%
Market value
‪26.09 K‬
USD
BIB
ProShares Ultra Nasdaq Biotechnology
Weight
0.02%
Market value
‪22.58 K‬
USD

Explore more ETFs